Results 221 to 230 of about 2,838,728 (307)

Outcomes of Nivolumab‐Plus‐Ipilimumab in Metastatic Renal Cell Carcinoma: Second Interim Analysis of the J‐ENCORE Study

open access: yesInternational Journal of Urology, EarlyView.
ABSTRACT Objectives J‐ENCORE is a multicenter prospective observational study in Japan involving advanced or metastatic renal cell carcinoma patients receiving nivolumab‐plus‐ipilimumab (NIVO+IPI) as first‐line treatment. The minimum 1‐year observation revealed the efficacy and safety of NIVO+IPI comparable to those in CheckMate 214, and evaluated ...
Tomokazu Sazuka   +14 more
wiley   +1 more source

Effect of continuous renal replacement therapy on serum levels of inflammatory cytokines/interleukin-17 in severe acute pancreatitis

open access: diamond
Diana Iosif   +9 more
openalex   +2 more sources

Time-course proteomic analysis of taurocholate-induced necrotizing acute pancreatitis

open access: bronze, 2013
Vanessa Fétaud-Lapierre   +6 more
openalex   +2 more sources

Safety of Potassium‐Competitive Acid Blockers Compared With Proton Pump Inhibitors in Patients With Gastroesophageal Reflux Disease and Peptic Ulcer Disease: A Systematic Review and Meta‐Analysis

open access: yesJournal of Gastroenterology and Hepatology, EarlyView.
ABSTRACT Background and Aim Potassium‐competitive acid blockers (P‐CABs) are a novel class of acid suppressants developed to overcome the limitations of proton pump inhibitors (PPIs), providing rapid and sustained acid suppression. While PPI‐related adverse events (AEs) are well‐documented, safety data on P‐CABs remain limited.
Yewon Jang   +6 more
wiley   +1 more source

GLP‐1 Receptor Agonist Therapy and Cardiorenal Outcomes in Patients ≥ 80 Years Old With Type 2 Diabetes

open access: yesJournal of the American Geriatrics Society, EarlyView.
Effect of glucagon‐like peptide‐1 receptor agonist therapy on cardiorenal outcomes in patients aged ≥ 80 years with Type 2 diabetes. ABSTRACT Background Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) have demonstrated potential in improving glycemic control and reducing adverse outcomes in patients with Type 2 diabetes mellitus (T2DM); however ...
Jui‐Cheng Chen   +4 more
wiley   +1 more source

Immediate Endoscopic Necrosectomy for Walled‐Off Pancreatic Necrosis: A First‐Choice Option?

open access: yes
Digestive Endoscopy, EarlyView.
Tsuyoshi Hamada   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy